WASHINGTON — Moderna officials say while its COVID-19 vaccine’s protection is holding up, it’s planning for booster doses to help fight the highly contagious delta variant.
With “the rising force of infection” from that variant and eventual waning immunity, a “booster will likely be necessary to keep us as safe as possible” this winter, Moderna President Dr. Stephen Hoge told investors.
